Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$30.19 - $40.28 $60,380 - $80,560
-2,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$29.09 - $45.68 $378,170 - $593,840
-13,000 Reduced 86.67%
2,000 $84,000
Q2 2021

Aug 16, 2021

SELL
$32.46 - $40.48 $486,900 - $607,200
-15,000 Reduced 50.0%
15,000 $583,000
Q1 2021

May 17, 2021

BUY
$33.61 - $49.95 $1.01 Million - $1.5 Million
30,000 New
30,000 $1.02 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.